Phase II.

Scroll

Maximize the value of your asset at phase II clinical milestones.

Our experts know the importance of Phase II clinical milestones, including proof of concept efficacy, dosing and initial benefit-risk assessment. Positive trial outcomes will likely require investment in carefully considered activities delivered with precision to maximize value creation.

With expert Advisory, Medical, MarComms, and Engagement services, coordinated through a single strategic point of contact, we have the expertise required to help you maximize the value of your asset when you receive positive Phase II data readouts.

Download the ebook

Explore Inizio Biotech

Phase I Phase 2 Phase 3

Key Phase II services.

Our services are highly personalized to the scope and scale you require. These are some common services we deliver to companies with Phase II assets:

Scientific communication platform to underpin all communications activities

Key Opinion Leader (KOL) mapping and engagement including Digital Sphere of Influence (DOL)

Experience maps including patient journey, practice standards and buying process

Value, pricing and access including forecasts for investors and create access-focused value proposition

Evidence generation plan to maximize future investments

Related insights.

Explore our resources

How can emerging biotechs strengthen their journey to commercialization?

As emerging biotech companies prepare for launch, it’s essential to prepare to maximize their future commercial potential.

When and why medical expertise is needed in the emerging biotech journey

It’s never too early to engage with and start thinking about medical affairs.

Bridging the gap between science-driven and commercially-minded decisions in emerging biotech

Shape a strategy that will build a value story around your asset.

Essential advice for emerging biotech

No two emerging biotechs are the same, and your strategy should be as unique as you are. Get our top tips to realizing your full potential.

Your market-leading commercialization partner.

Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.

Speak to one of our team